INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`PTOISBI'DBa (03-15)
`Doc code: IDS
`Approved for use through 071312016. OMB 0651-0031
`.
`.
`.
`_
`.
`.
`us. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`DOC description. Information Disclosure Statement (IDS) Flled
`Under the Paperwork Reduction Act Of 1995. no persons are required to respond to a collection Of information unless it contains a valid OMB control number.
`
`I—Application Number
`Filing Date
`First Named Inventor
`
`Art Unit
`
`
`
` Attorney Docket Number
`
`Examiner Name
`
`J. Mcdonald
`
`I AVN-OOQDVCNB
`
`
`
`
`
`u.s.PATENTS -
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code1 Issue Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`If you wish to add additional US. Patent citation information please Click the Add button. Add
`U.S.PATENT APPLICATION PUBLICATIONS -
`
`
`
`
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`Examiner Cite No Publication
`Initial*
`Number
`
`
`Publication
`Kind
`Code1 Date
`
`Name of Patentee or Applicant
`of cited Document
`
`0170283799
`
`“017 1005
`
`'0170292125
`
`'017— 10- 12
`
`AZANI et al.
`
` 1
`
`2
`
`
`
`
`
`
`
`
`If you wish to add additional U.S. Published Application Citation information please Click the Add button. Add
`FOREIGN PATENT DOCUMENTS -
`
`
`Examiner Cite Foreign Document
`Initial*
`No
`Number3
`
`
`Country
`Code2i
`
`Kind
`Publication
`Code4 Date
`
`Name of Patentee or
`.
`.
`Appllcant Of c'ted
`Document
`
`Pages,Columns,Lines
`where Relevant
`Passages or Relevant
`.
`FIgures Appear
`
`1
`2
`
`'017/059131 |. 2017—04—06
`014,172659 |.I
`
`20144023
`
`~areptaTherapeutics,Inc
`
`es Inst At Nationwide
`hildren 3 Hospital
`
`EFS Web 2.1.17
`
`
`
`
`
`

`

`
`
`
`
`Application Number 15349778
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`
`Filing Date
`2016-11-11
`First Named Inventor
`Peter SAZANI
`
`Art U .
`mt
`I 1674
`
`Examiner Name
`J. Mcdonald
`
`I AVN-OOQDVCNB
`
` Attorney Docket Number
`
`..areptaTherapeutics,Inc
`2013—09—26
`A1
`ll'013l142087
`
`
`
`
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`
`NON-PATENT LITERATURE DOCUMENTS
`
`
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`Examiner Cite
`T5
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`
`
`publisher, city and/or country where published.
`
`
`
`
`
`
`xtended European Search Report, EP 161723549, dated January 23, 2017, 7 pages.
`
`xtended European Search Report, EP 1715932813, dated September 5, 2017, 10 pages.
`
`
`If you wish to add additional non-patent literature document citation information please click the Add button
`
`
`EXAMINER SIGNATURE
`
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`
`
`EFS Web 2.1.17
`
`

`

`
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`
`
`Application Number 15349778
`
`Filing Date
`2016-11-11
`First Named Inventor
`Peter SAZANI
`
`Art U .
`
`mt
`I 1674
`Examiner Name
`J. Mcdonald
`
` Attorney Docket Number
`
`
`
`
`
`I AVN-009DVCN6
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`X A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`
` NamelPrint
`Signature
`2017—10—27
`
`
`
`